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Objective: To assess whether baseline LV dysfunction (LVEF) impacts the outcome of STEMI patients undergoing PCI, we studied the impact of LVEF 
on pt outcomes in the HORIZONS-AMI trial.
Methods: In the HORIZONS-AMI trial, pts were randomly assigned to receive unfractionated heparin (UFH) plus a glycoprotein IIb/IIIa inhibitor 
(GPI) or bivalirudin alone. Endpoints included non-CABG major bleeding, MACE including death, reinfarction, ischemic target vessel revascularization 
[TVR] or stroke, NACE (non-CABG major bleeding or MACE), and definite or probable stent thrombosis by ARC criteria.
Results: A total of 2,648 (73.5%) of 3,602 pts with LVEF were divided into 3 groups (1) LVEF <35% in 4.6%; (2) LVEF 35-50% in 18.8%; and (3) 
LVEF >50% in 76.5%. Pts with LVEF <50% had more prior MI, prior PCI, and Killip class >2 than normal LVEF pts. Outcomes are tabulated. A reduced 
LVEF (HR1.13 [1.05, 1.23], p= 0.0017) and LVEF 35-50% (2.64 [1.34, 5.23], p=0.005) predicted 1 year death.
Conclusion: Among patients with STEMI undergoing PCI, a reduced LVEF is associated with death, major bleeding, NACE and MACE at 1 year and 
even moderate LV dysfunction is a strong independent predictor of 1 year mortality. 
EF < 35% EF 35 - 50% EF≥ 50% p
Outcomes at 1-year (N) 123 499 2026
NACE (%, [n]) 30.2% (37) 17.0% (84) 14.3%(284) <0.0001
MACE (%, [n]) 20.4% (25) 12.6% (62) 9.5% (188) <0.0001
Death 13.1% (16) 5.1% (25) 2.1% (41) <0.0001
Reinfarction 6.3% (7) 3.6% (17) 3.5% (69) 0.3518
TVR for Ischemia 8.9% (10) 5.9% (28) 6.1% (119) 0.4836
Stroke 0.9% (1) 1.2% (6) 0.9% (18) 0.7954
Major Bleeding (non-CABG) 16.5% (20) 6.9% (34) 6.7% (134) 0.0001
Stent Thrombosis (%, N) 117 478 1891
Definite 2.7% (3) 2.7% (12) 2.6% (47) 0.9951
Probable 1.8% (2) 0.7% (3) 0.2% (3) 0.0058
